Results 31 to 40 of about 20,705 (157)

DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE IN BULK AND INHALER FORMULATION [PDF]

, 2022
Objective: To develop a simple, accurate, precise, rapid and sensitive method for the simultaneous estimation of Formoterol fumarate and Aclidinium bromide in pharmaceutical dosage form. Methods: The chromatogram was run through Ascentis C18 150 x 4.6 mm,
ABHISHEK, K., BALAJI, P. V., PRIYANKA, Y. LEELA, LAKSHMI, A. JAYA, ASHRITHA, N.   +4 more
core   +1 more source

Faster Onset of Bronchodilation with Formoterol than with Salmeterol in Patients with Stable, Moderate-Severe Copd: Results of a Randomized, Double-Blind Clinical Study

Canadian Respiratory Journal, 2002
OBJECTIVES: To compare the onset and magnitude of bronchodilation after dry powder inhalations of formoterol fumarate (Foradil Aerolizer) versus salmeterol xinofoate (Serevent Diskus) with respect to normalized (*) forced expiratory volume in 1 s area ...
John Kottakis, Giovanni Della Cioppa, Jacques Creemers, Louis Greefhorst, Violette Leclerc, Riccardo Pistelli, Tim Overend, Denise Till, Günter Rapatz, Vincent LeGros, Demosthenes Bouros, Nikolaos Siafakas   +11 more
doaj   +1 more source

Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. [PDF]

, 2013
BACKGROUND: Asthma is characterised by chronic inflammation of the airways and recurrent exacerbations with wheezing, chest tightness and cough. Treatment with inhaled steroids and bronchodilators often results in good control of symptoms, prevention of ...
Mindus, SM, Ferrara, G, Ferrara, G,, Kew, KM, Karner, C   +4 more
core   +1 more source

Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS

International Journal of COPD, 2021
Fernando J Martinez,1 Gary T Ferguson,2 Eric Bourne,3 Shaila Ballal,4 Patrick Darken,5 Magnus Aurivillius,6 Paul Dorinsky,3 Colin Reisner4 1Joan and Sanford I.
Martinez FJ, Ferguson GT, Bourne E, Ballal S, Darken P, Aurivillius M, Dorinsky P, Reisner C   +7 more
doaj  

Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children [PDF]

, 2008
BackgroundCombination therapies are frequently recommended as maintenance therapy for people with asthma, whose disease is not adequately controlled with inhaled steroids.
Christopher J Cates, Lasserson, TJ, Giovanni Ferrara, Ferrara, G, Toby J Lasserson, Cates, CJ, Casali, L, Lucio Casali   +7 more
core   +1 more source

Bone and ocular safety of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a 52-week randomized study

Respiratory Research, 2019
Background Long-term use of inhaled corticosteroids (ICSs) has been associated with increased risk of bone and ocular comorbidities. We evaluated the effects of the triple fixed-dose combination budesonide/glycopyrrolate/formoterol fumarate metered dose ...
Edward M. Kerwin, Gary T. Ferguson, Mindy Mo, Kiernan DeAngelis, Paul Dorinsky   +4 more
doaj   +1 more source

Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi [PDF]

, 2014
Long-acting muscarinic receptor antagonists (LAMAs) and long-acting β2-adrenoceptor agonists (LABAs) cause airway smooth muscle (ASM) relaxation via different signal transduction pathways, but there are limited data concerning the interaction between ...
Matera MG, Cazzola M, Calzetta, L, Calzetta, Luigino, Calzetta L, Rogliani P, Rogliani, Paola, Gavaldà, A, Gavaldà A, Facciolo, F, Page CP, Page, Clive P., Gavaldà, Amadeu, Cazzola, Mario, Page, C, Facciolo, Francesco, Facciolo F, Matera, Maria Gabriella, Matera, M.   +18 more
core   +1 more source

Perioperative Nivolumab in Resectable Non‐Small Cell Lung Cancer: A Subanalysis of Japanese Patients From CheckMate 77T

Cancer Science, Volume 117, Issue 3, Page 759-768, March 2026.
ABSTRACT In the randomized phase III CheckMate 77T study, perioperative nivolumab showed statistically significant and clinically meaningful improvement in event‐free survival (EFS) vs. placebo in patients with resectable, non‐metastatic non‐small cell lung cancer (NSCLC).
Fumihiro Tanaka, Yasutaka Watanabe, Shunichi Sugawara, Jiro Okami, Satoshi Muto, Morihito Okada, Yoshitsugu Horio, Masahiro Tsuboi, Yuki Sato, Kazuya Takamochi, Hidehito Horinouchi, Yuichi Tambo, Masahiro Seike, Kyoichi Okishio, Cinthya Coronado Erdmann, Padma Sathyanarayana, Stephanie Meadows‐Shropshire, Hiroyuki Ito   +17 more
wiley   +1 more source

Six‐Year Trends in Real‐World Data Use for Post‐Marketing Surveillance of New Medical Products in Japan

Clinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT The Ministerial Ordinance on Good Post‐Marketing Study Practice for Drugs was amended by the Ministry of Health, Labour and Welfare (MHLW) in 2018 to clearly define post‐marketing database studies (DBS) as a measure of pharmacovigilance activities for approved medical products in Japan.
Suguru Okami, Kako Shimotsumagari, Yasunari Sadatsuki   +2 more
wiley   +1 more source

Cost-effectiveness of budesonide-formoterol in maintenance therapy of asthma patients at Mexico’s National Center for Respiratory Diseases.

Revista Alergia México
Objective: to perform a cost-effectiveness analysis of asthma treatment with budesonide/formoterol against other treatment options used at Mexico’s National Institute for Respiratory Diseases.
María del Carmen Cano-Salas, José L. Miguel-Reyes, Erika C. López-Estrada, Jorge Salas-Hernández, Monserrat E. Arroyo-Rojas, Mauricio Castañeda-Valdivia, Monserrat Escobar-Preciado, Homero Garcés-Flores, Silvia Guzmán- Vázquez, Sergio R. García-García, Herman Soto-Molina   +10 more
doaj   +1 more source